Hematology TimesGroup quantifies cardiotoxicity risk with HL treatmentNovember 19, 2015Lymphoma & Plasma Cell DisordersHodgkin Lymphoma
Hematology NewsStudy: Pediatric cancer patients have high rate of germline mutations in predisposition genesNovember 18, 2015ALLPediatricsLymphoma & Plasma Cell DisordersPreventive Care
Hematology TimesTeam characterizes EMH nicheNovember 18, 2015CythemiasAnemiaLeukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersMultiple MyelomaTransplantation
Hematology NewsFDA approves daratumumab for multiple myelomaNovember 16, 2015Multiple MyelomaLymphoma & Plasma Cell Disorders
Hematology TimesESRD treatments linked to different cancersNovember 13, 2015Lymphoma & Plasma Cell DisordersHodgkin LymphomaNon-Hodgkin Lymphoma
Hematology TimesDrug ‘life-changing’ for CLL patients in phase 1 trialNovember 12, 2015Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersNon-Hodgkin LymphomaFollicular Lymphoma
Hematology TimesInhibitor exhibits ‘modest’ activity in lymphomaNovember 12, 2015Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersMultiple MyelomaHodgkin LymphomaNon-Hodgkin LymphomaFollicular Lymphoma
Hematology NewsMultiple myeloma advances in diagnosis, staging, therapy extend survivalNovember 11, 2015Multiple MyelomaLymphoma & Plasma Cell Disorders
Hematology TimesCCSs have increased risk of autoimmune diseasesNovember 11, 2015Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersPediatricsHodgkin Lymphoma
Hematology NewsITC 2015: Review IDs features to aid thyroid lymphoma diagnosisNovember 10, 2015Rare DiseasesLymphoma & Plasma Cell DisordersFollicular Lymphoma
Hematology TimesDrug protects fertility in chemo-treated miceNovember 10, 2015Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersMultiple MyelomaPediatrics
Hematology TimesFDA grants drug priority review as FL therapyNovember 6, 2015Lymphoma & Plasma Cell DisordersPharmacyNon-Hodgkin Lymphoma
Hematology TimesBreast cancer drug may also work in MCL, myelomaNovember 6, 2015Lymphoma & Plasma Cell DisordersMultiple MyelomaNon-Hodgkin Lymphoma
Hematology NewsNew therapies finding their place in management of follicular lymphomaNovember 5, 2015Indolent LymphomaLymphoma & Plasma Cell DisordersFollicular Lymphoma
Hematology NewsLenalidomide plus rituximab achieves 87% response rateNovember 4, 2015Mantle Cell LymphomaLymphoma & Plasma Cell DisordersMelanoma
